Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 10 of 43
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Anti-HCV, HBsAg Positive Incidences Among Patients Aged 40 Years and Over Diagnosed with B- Non-Hodgkin’s Lymphoma: A Comparison with General Population of Same Age
    (Mongolian National University of Medical Sciences, 2019-12-29) ;
    Delgerbat Boldbaatar
    ;
    Anir Enkhbat
    ;
    ;
    Khishigjargal Batsukh
    Objectives: There are several risk factors contribute to the development of the B-cell Non-Hodgkin’s lymphoma (B-NHL) among which hepatitis B, hepatitis C virus (HBV, HCV) infection, as well as old age, are known to have a signi cant effect. Previous studies examining the relationship between HBV, HCV infection and B-NHL show inconsistent results in different endemic areas. Methods: We compared the hepatitis B surface antigen (HBsAg) and antibody against the HCV (anti-HCV) positive incidences among aged 40 years or older patients who have been newly diagnosed with B-NHL, between 2015 and 2018, to prevalence of hepatitis B and C virus infection in the general population of Mongolia in the same age by data of the general population in hepatitis screening and the results of previous studies on the Mongolian population. Results: A total of 187 patients, newly diagnosed with B-NHL ≥40years of age took part in our study. In case of these two groups, the prevalence of HBsAg in the B-NHL population was close to the general population while anti-HCV positive was signi cantly higher in the B-NHL group (p<.00001). Conclusion: Further studies are needed to clarify the reasons and contributing factors which result situations where the HBV prevalence among B-NHL patients and the general population are not signi cantly different.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Helicobacter Pylori Genotyping Among Mongolian Dyspeptic Patients
    (Mongolian National University of Medical Sciences, 2022-06-30)
    Tserentogtokh Tegshee
    ;
    ; ; ;
    Battulga Adiyasuren
    Objective: The prevalence of H. pylori infection varies significantly and developing countries are found to be the highest in Asia. In the present study, we have aimed to perform a combined analysis of histochemical stains and IHC to confirm the H.pylori infection of patients in 5 different provinces and Ulaanbaatar city, Mongolia. Method: Five hundred and thirty-eight patients were enrolled in this study (142 gastric mucosal atrophy, 333 gastritis and 62 gastroesophageal reflux). Results: 67.1 % of participants had CagA positive and 69.3 % were immunohistochemically positive. All histological results showed that the gastritis group was significantly higher in patients who were positive for H. pylori than in antral-predominant gastritis. By the hematoxylin and eosin staining with May– Giemsa confirmation by IHC, the prevalence of H. pylori infection in the gastric mucosal atrophy group was 62.1 %, while in the gastritis and gastroesophageal reflux group, the rate was 74.3 % and 59.1 %, respectively. Conclusion: CagA sequence profile in each group of patients revealed that 22.6 % of the gastric mucosal atrophy group was ABC type, 43.4 % was ABCC type and 33.9 % was ABTC type. On the other hand, in the gastritis group, the dominant type was ABTC (41.3 %). In the gastroesophageal reflux group, the ABCC type was dominant while 23.1% was the ABC type.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    IDDF2019-ABS-0021 Diagnostic colonoscopy for diverticular disease in ub songdo hospital
    (2019-06-01)
    Bayasgalan Luvsandagva
    ;
    Battulga Adiyasuren
    ;
    Narantsatsralt Jalbuu
    ;
    ;
    Background Colonic diverticulum rises on blood vessel penetration site of colonic smooth muscle through the herniation process. Commonly asymptomatic and found incidentally during colonoscopy. But it could turn in to life-threatening disease once bleeding, inflammation or perforation occurs. The aims of this study were to detect the incidence of complicated diverticular disease and diagnostic accuracy of colonoscopy in diverticular disease compared with abdominal contrast-enhanced computed tomography (CT). Methods This retrospective study included a total of 321 patients with colonic diverticulum diagnosed by lower gastrointestinal endoscopy within the past 8 years in Gastroenterology and Endoscopy department of Ulaanbaatar Songdo Hospital, Ulaanbaatar city, Mongolia. The borderline between the proximal and distal colon was splenic flexure. Chi-square and student t-test were used to differentiate the two groups. P>0.05 was statistically significant. Results The mean age of patients with colonic diverticulosis 58.67±14.45 and incident of diverticulosis increased in elderly patients ( t=-4.439; P<0.001) and female were predominant (λ2=78.82; P<0.001). Diverticulitis is a common complication and more frequently in patients with distal diverticulosis group (λ2=9.97; P<0.001), diverticular bleeding more frequently in patients with proximal diverticulosis (λ2=13.49; P<0.001) (table 1). Age, gender, complicated diverticular diseases divided by location of colonic diverticulosis is shown in table 2. Distal diverticulosis was predominant in female patients group and proximal diverticulosis was predominant in male patients group (table 2). A total number of 79 patients were examined by both colonoscopy and CT together in approximate time. But 72.2% of results have missed the diverticulum and 22.2% of diverticulitis cases were misdiagnosed by suspected colonic cancer. Conclusions The incidence of complicated diverticular disease around 6.5% in patients with colonic diverticulosis. The diverticulitis occurs more frequently than diverticular associated bleeding. The colonoscopy has higher diagnostic accuracy for colonic diverticulosis and complicated diverticular disease compared with abdominal contrast-enhanced computed tomography.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Impact of Hepatitis D Coinfection on the Hepatitis Flare during Chemotherapy for B-Cell Non-Hodgkin Lymphoma
    (Mongolian National University of Medical Sciences, 2020-04-01) ;
    Anir Enkhbat
    ;
    Delgerbat Boldbaatar
    ;
    Khishigjargal Batsukh
    ;
    Altankhuu Murdoj
    Objectives: This study was conducted to determine the effect of Hepatitis B infection with or without D coinfection on the hepatitis flare associated with chemotherapy for B-Cell non-Hodgkin lymphoma. Methods: The hepatitis flare related to the chemotherapy for newly diagnosed B-Cell non-Hodgkin lymphoma was studied in HBV mono-infected and HBV and HDV coinfected patients between 2015 and 2018. Results: Nineteen HBsAg positive patients satisfied the inclusion criteria. In the group with the hepatitis flare, 14.3% were anti-HDV negative and 83.3% were anti-HDV positive (p<.006). Also, the hepatitis flare occurred in all patients where HDV-RNA was detected, while it had occurred in 60% of patients where HDV-RNA was not detected. Conclusion: The hepatitis flare related to chemotherapy occurred more frequently in B-Cell non-Hodgkin lymphoma patients coinfected with HBV and HDV without antiviral prophylaxis, especially when HDV-RNA was detected.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Hepatitis C Associated B-Cell Non-Hodgkin Lymphoma: Impact of Combination Direct-Acting Antivirals and Chemotherapy
    (Mongolian National University of Medical Sciences, 2021-12-31) ;
    Delgerbat Boldbaatar
    ;
    Khishigjargal Batsukh
    ;
    ;
    Objectives: Direct-acting antiviral agents (DAAs) have successfully eradicated chronic hepatitis C virus (HCV) infection. Since chronic HCV is known to have an increased risk of developing B cell non-Hodgkin lymphoma (B-NHL), successful HCV treatment may have virologic, hepatic, and oncologic benefits for B-NHL. Therefore, this study aimed to determine the efficacy of DAAs combined with chemotherapy in B-NHL patients with chronic HCV in Mongolia. Methods: This case-control study included newly diagnosed B-NHL patients with chronic HCV who received DAAs before chemotherapy (with DAAs group). The other is comprised of controls who have been treated by chemotherapy without DAAs. Patients who received courses of DAAs were monitored by the virological and hepatic responses. Results: Eleven patients received DAAs and none of them developed chemotherapy-associated hepatitis flare. Of the DAAs group, during DAAs treatment, 90.9% were clinically stable. In all cases of DAAs in combination with chemotherapy, the Sustained Viral Response (SVR)12 and 24 were 100%. However, 47.4% of those who received DAAs after chemotherapy developed hepatitis flare during chemotherapy. Patients with hepatitis flare had higher serum level of ALT before chemotherapy (15.7 U/L vs. 40.2 U/L; p = 0.014) than those without. Conclusion: DAAs administration results in a significant clinical benefit to B-NHL patients with chronic HCV.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Diagnosis of severe life-threatening decompensated liver cirrhotic complication via cytokines
    (2022-11-14)
    Bayarmaa Ochirkhuree
    ;
    Ayush Khangai
    ;
    ;
    Background: Mongolia is known to be the leading country in the world for liver cancer. The primary cause of liver cancer evidently reported were hepatic virus such as HCV, HBV and HDV. The high mortality of patient with liver cirrhosis is mostly due liver decompensation related complication such as GI bleeding, hepatic failure, infection mostly due to spontaneous bacterial peritonitis (SBP). In this study we aimed to determine the SBP in early stages through examination of cytokines from peritoneal fluid. Methods: Study was conducted among 58 hospitalized patients at the Gastroenterology Center of The FCHM between February to September 2020, who were diagnosed with liver cirrhosis and ascites. Ascites fluid was aspirated following the hospital protocol via abdominal tab with a 16-inch needle guided by ultrasonography on the day 1 of hospitalize and examined for IL-4, IL-6 and INF-gamma. Results: The average age for patients was 52.5 and 31 (53.4%) were males. The hepatic viral cirrhosis was 52 (89.6%). Of the total cases, 28 (48.2%) were CTP-B, and 30 (51.8%) were CTP-C and the mean model for end-stage liver disease score was 20.6. The SBP and non-SBP groups characteristics presented in table 1. Best cut-off value to determine SBP for IL-6 was 629.78 pg/mL with sensitivity and specificity both 100% in Mongolian patients. Conclusions: In patient with liver cirrhosis, elevated IL-6 level (more than 630 pg/mL) in ascites can predict the SBP status as early as possible in limited secondary hospital and to start antibiotic treatment also as early as possible.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Donor’s quality of life after living donor liver transplantation and influencing factors in Mongolia
    (2022-11-15)
    Munkhzaya Chogsom
    ;
    Nasantogtokh Erdenebileg
    ;
    ;
    Background: Improving the quality of living liver donor's postdonation is an important aspect of care quality. In addition, there are many factors that affect the quality of life. In Mongolia, evidence-based information on the quality of life of living donors is few. This study aims to propose the quality of life of living donors who donated organs for liver transplantation and influencing factors.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    P.389: No difference in recurrent hepatocellular carcinoma rates in liver transplanted patients receiving mTOR inhibitors compared to non-mTOR group.
    (Wolters Kluwer, 2024-09-01)
    Anar Ganbold
    ;
    Margad-Erdene Erdenechuluun
    ;
    Bayarmaa Ochirkhuree
    ;
    Urnultsaikhan Ganbold
    ;
    Ulzii-Orshikh Namkhai
    Introduction: A liver transplantation (LT) is a first line therapeutic choice for patients with hepatocellular carcinoma (HCC). Mammalian Target of Rapamycin (mTOR) inhibitors act as immunosuppressant and indicated against HCC recurrence in LT patients. The efficacy of mTOR inhibitors in preventing HCC recurrence remains contentious. Methods: We retrospectively enrolled 45 patients (average age 50, M/F:29/16) who had a history of HCC at the time of LT operation at a single center (2011-2023) and divided into a mTOR and non-mTOR groups. Initial Alfa-fetoprotein (AFP), Protein induced by vitamin K absence-II (PIVKA-II) levels, contrast-enhanced abdominal computer-assisted tomography (CT) scans were compared to most recent results, explant histology was also assessed for HCC extent. Decision to transplant was made based on Milan criteria. Student t-test was used to determine statistical significance (p<0.05). Results: In the mTOR group (n=23, average age 52.7) there were 2 confirmed HCC recurrences with elevated markers and positive CT scans. In the non-mTOR group (n=22, average age 47.4) there was 1 confirmed case of HCC. A recurrence rate of 6.67% was recorded overall, 8.7% and 4.55% for mTOR and non-mTOR (p=0.28), respectively. All three recurrences were detected within 24 months of the operation. For recurrent HCCs, the average levels of PIVKA-II and AFP were 27010mAU/ml and 2842.7ng/ml, respectively. There was no difference in number and mode of pre-LT bridging therapies (TACE or RFA) with regards to recurrence. There were two cases of elevated PIVKA-II without a radiologic confirmation. Conclusion: Adherence to the Milan criteria and application of pre-LT bridging therapies will keep the recurrence rate below 10%. Any possible recurrence will be diagnosed within 24 months of LT. Administration of mTOR inhibitors can be stopped after 2 years as part of the physician-guided minimization of immune suppression regimen.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Ходоодны хорт хавдрын оношилгоонд КТ-ийн шинжилгээний үүрэг
    (2020-05-01)
    Я.Энхтуул
    ;
    Д.Мөнхбаатар
    ;
    Д.Түвшинжаргал
    ;
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Functional Abnormalities of the Liver in Diabetic Patients with and without Hepatitis C
    (Mongolian National University of Medical Sciences, 2019-03-31) ; ; ; ;
    Objective: We aimed to compare liver function of diabetes mellitus patients with and without viral hepatitis C using the non-alcoholic fatty liver disease fibrosis score, aspartate transaminase to platelet ratio index, Fibrosis-4 Index, Mac-2-binding protein biomarker and ultrasonic liver stiffness measurements. Methods: The study was conducted based on convenience sampling of 123 patients. Slightly more than half of the study participants were male (53%, n=64). Thirty-three of the diabetics with hepatitis (mean age 52.31±9.8 years) and 90 diabetics without hepatitis (mean age 53.26±8.58) agreed to participate. Anthropometric measurements, non-alcoholic fatty liver disease fibrosis score, aspartate transaminase to platelet ratio index, Fibrosis-4 Index, Mac-2-binding protein biomarker, and ultrasonic transient elastography measurements were compared using independent t-tests for continuous variables and Wilcoxon rank sum tests for ordinal variables. Results: The median values of the Fibrosis-4 Index for those with and without hepatitis C were 1.3 vs. 0.9 (p<.05), Mac-2-binding protein biomarker 2.0 vs. 1.3 (p<.0001), ultrasonic liver stiffness measurements 10.3 vs. 6.9 (p<.0001), aspartate transaminase to platelet ratio 0.6 vs. 0.3 (p<.001), and Non-alcoholic fatty liver disease fibrosis scores were -0.2 vs. -0.9 ( p<.004), respectively Conclusions: Diabetic patients with hepatitis had statistically significantly higher Mac-2-binding protein biomarker, NAFLD Fibrosis Scores than patients without hepatitis. However, other fibrosis test results were similar in diabetic patients with hepatitis and without hepatitis C.